Effect of suramin on human interferon alpha binding to cell receptors

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Interferon (IFN) signaling is crucial for immune responses.
• Daudi cells, a Burkitt lymphoma line, express high-affinity IFN receptors.
• Understanding IFN-receptor interactions is key to developing antiviral and anticancer therapies.

Purpose of the Study:

• To investigate the effect of suramin on the binding and interaction of human recombinant interferon alpha 88 (IFN-alpha 88) with its receptors on Daudi cells.
• To determine the temperature-dependent efficacy of suramin in modulating IFN-receptor complex formation and stability.

Main Methods:

• Radioiodinated IFN-alpha 88 (125I-IFN-alpha 88) binding assays on Daudi cells.
• Treatment with suramin at varying concentrations and temperatures (4°C and 37°C).
• Assessment of IFN-receptor complex dissociation and downstream signaling (2-5A synthetase activity) and receptor regulation.

Main Results:

• Suramin (105-175 microM) completely inhibited 125I-IFN-alpha 88 binding at 4°C.
• At 37°C, suramin's inhibitory effect was partial and time-dependent, indicating reduced efficacy.
• Suramin dissociated initial IFN-receptor complexes but failed to dissociate complexes formed or internalized at 37°C, preventing downstream effects.

Conclusions:

• Suramin effectively blocks initial IFN-alpha 88 binding to cell surface receptors at low temperatures.
• The stability and accessibility of IFN-receptor complexes increase with temperature, rendering them less sensitive to suramin.
• These findings suggest distinct stages in IFN-receptor complex formation and stabilization, impacting therapeutic interventions.